Skip to main content

Table 1 Baseline characteristics of study population.

From: Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy

Overall population

N

35

Age, years

65 ± 15

Male/Female

23/12

SOFA

13 ± 2.5

Organ dysfunction, n

4 ± 0.8

APACHE II

23 ± 5

ICU mortality, n (%)

14 (40)

Hospital mortality, n (%)

16 (45.7)

Patients with previous renal impairment*

11 (31%)

Medical, n (%)

15 (43%)

Surgical, n (%)

20 (57%)

Urea, mmol/L

13.5 ± 9.7

Creatinine, μmol/L

198.1 ± 108.4

  1. Data are expressed as absolute number (n), percentage or mean ± SD.
  2. * Impaired renal function was defined as patients receiving chronic dialysis or with documented elevated creatinine prior to current illness.
  3. APACHE = Acute Physiology and Chronic Health Evaluation, ICU = intensive care unit, SOFA = Sequential Organ Failure Assessment.
Back to article page

Critical Care

ISSN: 1364-8535